Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • ROOMS:

CBD of Denver Inc. Announces Luxora Has Signed 4 Letters of Intent to Build and Manage 4 Cannabis Clubs in Germany

By: Newsfile

Denver, Colorado--(Newsfile Corp. - September 14, 2023) - CBD of Denver, Inc. (OTC Pink: CBDD), is pleased to announce that its wholly owned Luxora subsidiary has signed 4 Letters of Intent to build production facilities to support 4 Cannabis Clubs with its "Production Facility Rental Model" located in Germany.

"Luxora has during its first few days after offering its services has already signed 4 letters of intent for Cannabis Clubs. This level of activity demonstrates the demand for this concept in Germany," states Jan Schwager CEO of Luxora. "We are very pleased with the initial two of days of activity as this reinforces our belief in this business opportunity. Luxora has been positioning itself to be a leader in this space, due to the depth of our diverse management experience and our vision which includes our recent acquisition of HolistiCH enabling the company to offer exclusive strains to its clients. The company believes this strategy will separate us from the other players in the market giving us a competitive advantage and creating a barrier to entry." Groups entering into letters of intent with Luxora secure their place with a 75,000 Euro deposit.

The company will be building its first grow facility to support the Cannabis clubs with its production facility service which will supply the clubs with exclusive strains of Cannabis preparing for the finalization of the German legislation legalizing the cannabis club framework. This is another vertical in the Luxora revenue model adding to our wholesale and retail sales as well as integrating the clones and seeds from HolistiCH.

The company will provide updates as the company works closely with these 4 original groups and the Cannabis Club legislation is finalized by the German government.

Additional updates from CBD of Denver

  1. The company is repositioning Berliner Innovation, adding additional products that have already had success in North America to the existing product mix. The company will be adding a social media approach that is typical in North America, but not regularly used in Europe. The company believes this strategy will provide a robust stream of new products and new projects for the company.
  2. Libra 9 continues to expand distribution of the Magic Lappen in northern and southern Germany while continuing marketing efforts during exhibitions for household goods and automotive accessories.

The company wants to maintain a transparent relationship with its shareholders and please visit our websites and ask any question you feel is missing from our websites and public disclosures.


CBD of Denver, Inc. is focused on acquiring profitable assets at attractive valuations to create value for shareholders. The company's team is dedicated to sourcing high-margin, innovative products that align with its values. The Company is offering a number of innovative consumer products through Libra 9 GmbH, such as the Magic Lappen and the BerlinR13 Anti-Slip solution.

Follow Magic Lappen on Twitter, Instagram, Facebook and TikTok for more information and updates.

Follow The Magic Lappen on Instagram: @themagiclappen

Shop on our website:

Visit the CBDD/ Berliner Innovation:

See our innovative Anti-Slip product:

For questions, please contact us at:


LUXORA LLC is a trailblazing entity in the European cannabis industry, with offices spanning the USA and Europe. Our core expertise revolves around unlocking the potential of the legalized cannabis market, offering Plug & Play solutions tailored to the dynamic needs of this rapidly expanding sector. With a profound understanding of the opportunities and challenges brought forth by legalization, our experienced team is dedicated to pioneering the future of the legal cannabis market in Europe. Our offerings range from consulting and market research to product development and distribution solutions, aimed at simplifying the path to legalization for our esteemed clients.

For inquiries, please contact Investor Relations:

For more information, please visit:

Follow Us: Twitter | Instagram

To view the source version of this press release, please visit

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.